Hillis WS - Search Results

1

Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council.

Verheugt FW, Becker RC, Bertrand ME, Bode C, Chesebro JH, Cleland JG, Conti R, Hillis WS, Klein W, Maseri A, Turpie AG, Wallentin L, Waters DD. Verheugt FW, et al. Among authors: hillis ws. Clin Cardiol. 1999 Sep;22(9):551-3. doi: 10.1002/clc.4960220903. Clin Cardiol. 1999. PMID: 10486693 Free PMC article.

2

Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.

Klein W, Buchwald A, Hillis WS, Monrad S, Sanz G, Turpie AG, van der Meer J, Olaisson E, Undeland S, Ludwig K. Klein W, et al. Among authors: hillis ws. Am J Cardiol. 1997 Sep 4;80(5A):30E-34E. doi: 10.1016/s0002-9149(97)00487-6. Am J Cardiol. 1997. PMID: 9296467 Clinical Trial.

3

The continuing debate: conservative or interventional therapy for unstable coronary artery disease.

Hillis WS. Hillis WS. Am J Cardiol. 1997 Sep 4;80(5A):51E-54E. doi: 10.1016/s0002-9149(97)00491-8. Am J Cardiol. 1997. PMID: 9296471 Review.

4

Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland.

Hood S, Birnie D, Curzio JL, Hillis WS. Hood S, et al. Among authors: hillis ws. Health Bull (Edinb). 1996 Mar;54(2):131-9. Health Bull (Edinb). 1996. PMID: 8655300

5

Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction.

Carrick D, Behan M, Foo F, Christie J, Hillis WS, Norrie J, Oldroyd KG, Berry C. Carrick D, et al. Among authors: hillis ws. Am J Cardiol. 2013 Jan 1;111(1):45-50. doi: 10.1016/j.amjcard.2012.08.046. Epub 2012 Oct 2. Am J Cardiol. 2013. PMID: 23040601

6

The role of intervention following thrombolysis for acute myocardial infarction.

Hillis WS. Hillis WS. Eur Heart J. 1990 Aug;11 Suppl F:56-60. doi: 10.1093/eurheartj/11.suppl_f.56. Eur Heart J. 1990. PMID: 2226543 Review. No abstract available.

7

Effect of ketanserin on central haemodynamics and coronary circulation.

Hood S, Birnie D, Nasser A, Hillis WS. Hood S, et al. Among authors: hillis ws. J Cardiovasc Pharmacol. 1998 Dec;32(6):983-7. doi: 10.1097/00005344-199812000-00016. J Cardiovasc Pharmacol. 1998. PMID: 9869505 Clinical Trial.

8

Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction.

Hogg KJ, Gemmill JD, Burns JM, Lifson WK, Rae AP, Dunn FG, Hillis WS. Hogg KJ, et al. Among authors: hillis ws. Lancet. 1990 Feb 3;335(8684):254-8. doi: 10.1016/0140-6736(90)90069-h. Lancet. 1990. PMID: 1967720 Clinical Trial.

9

ST segment changes as a surrogate end point in coronary thrombolysis.

Hillis WS, Hogg KJ. Hillis WS, et al. Br Heart J. 1990 Aug;64(2):111-2. doi: 10.1136/hrt.64.2.111. Br Heart J. 1990. PMID: 2203396 Free PMC article. Review. No abstract available.

10

Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.

Gemmill JD, Hogg KJ, Dunn FG, Rae AP, Hillis WS. Gemmill JD, et al. Among authors: hillis ws. Br Heart J. 1994 Sep;72(3):222-5. doi: 10.1136/hrt.72.3.222. Br Heart J. 1994. PMID: 7946770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters